Linda Marc

Last updated

Dr. Linda Marc is a Haitian-American who is published in the areas of HIV/AIDS and minority health issues. [1] [2] [3] [4] In 2014 she was honored and placed on the '1804 List of Changemakers and One's to Watch' by the Haitian Round Table, an organization committed to civic engagement and philanthropic endeavors benefiting Haiti, Haitian organizations and causes. [5] [6] Her research has helped to dispel the myth about Haitians with AIDS, which challenged previous notions that Haitian immigrants have a higher prevalence of HIV/AIDS than all other ethnic groups. [7]

Marc is the former Chair of the Public Health Committee for the Association of Haitian-American Engineers (2005–2007), and was honored in 2005 with an award from the Haitian-Canadian Association of Engineers and Scientists (AIHC) in Canada. [8] In 2007 she was selected to serve on the Census Bureau's Race and Ethnicity Advisory Committee and was vice-chair of the Advisory Committee on the African American Population from 2007 to 2012. She was re-appointed by the Census Bureau (2012-2015) as the Convenor of the Race and Hispanic Research Working Group for the newly formed National Advisory Committee for Race, Ethnicity and Other Populations. [9]

Marc earned a Doctor of Science from the Harvard T.H. Chan School of Public Health, a Master of Public Health from Yale School of Public Health, and a BA in Psychology from St. John's University (New York).

Related Research Articles

HIV/AIDS has been a public health concern for Latin America due to a remaining prevalence of the disease. In 2018 an estimated 2.2 million people had HIV in Latin America and the Caribbean, making the HIV prevalence rate approximately 0.4% in Latin America.

<span class="mw-page-title-main">Epidemiology of HIV/AIDS</span> Epidemic of human immunodeficiency virus

The global epidemic of HIV/AIDS began in 1981, and is an ongoing worldwide public health issue. According to the World Health Organization (WHO), as of 2021, HIV/AIDS has killed approximately 40.1 million people, and approximately 38.4 million people are infected with HIV globally. Of these 38.4 million people, 75% are receiving antiretroviral treatment. There were about 770,000 deaths from HIV/AIDS in 2018, and 650,000 deaths in 2021. The 2015 Global Burden of Disease Study estimated that the global incidence of HIV infection peaked in 1997 at 3.3 million per year. Global incidence fell rapidly from 1997 to 2005, to about 2.6 million per year. Incidence of HIV has continued to fall, decreasing by 23% from 2010 to 2020, with progress dominated by decreases in Eastern Africa and Southern Africa. As of 2020, there are approximately 1.5 million new infections of HIV per year globally.

<span class="mw-page-title-main">Specioza Kazibwe</span> Ugandan politician

Speciosa Naigaga Wandira Kazibwe, is a Ugandan politician and first female vice president in Africa. She was the sixth vice president of Uganda from 1994 to 2003, making her the first woman in Africa to hold the position of vice-president of a sovereign nation. Dr. Speciosa Kazibwe is also a Ugandan surgeon. She is also referred to as "Nnalongo", because of her twins. In August 2013, she was appointed by the United Nations's Secretary General, Ban Ki-Moon as United Nations Special Envoy for HIV/AIDS in Africa.

<span class="mw-page-title-main">HIV/AIDS</span> Spectrum of conditions caused by HIV infection

Human immunodeficiency virus infection and acquired immunodeficiency syndrome (HIV/AIDS) is a spectrum of conditions caused by infection with the human immunodeficiency virus (HIV), a retrovirus. Following initial infection an individual may not notice any symptoms, or may experience a brief period of influenza-like illness. Typically, this is followed by a prolonged incubation period with no symptoms. If the infection progresses, it interferes more with the immune system, increasing the risk of developing common infections such as tuberculosis, as well as other opportunistic infections, and tumors which are rare in people who have normal immune function. These late symptoms of infection are referred to as acquired immunodeficiency syndrome (AIDS). This stage is often also associated with unintended weight loss.

<span class="mw-page-title-main">HIV/AIDS in Asia</span>

In 2008, 4.7 million people in Asia were living with human immunodeficiency virus (HIV). Asia's epidemic peaked in the mid-1990s, and annual HIV incidence has declined since then by more than half. Regionally, the epidemic has remained somewhat stable since 2000.

<span class="mw-page-title-main">Demographics of Africa</span>

The population of Africa has grown rapidly over the past century and consequently shows a large youth bulge, further reinforced by a low life expectancy of below 50 years in some African countries. Total population as of 2020 is estimated to be more than 1.3 billion, with a growth rate of more than 2.5% p.a. The total fertility rate for Sub-Saharan Africa is 4.7 as of 2018, the highest in the world according to the World Bank. The most populous African country is Nigeria with over 206 million inhabitants as of 2020 and a growth rate of 2.6% p.a.

<span class="mw-page-title-main">Awa Marie Coll-Seck</span> Senegalese infectious diseases specialist and politician

Awa Marie Coll-Seck is as Senegalese infectious diseases specialist and politician who served as Minister of Health of Senegal from 2001 to 2003 and again from 2012 to 2017. She also served as former Executive Director of the Roll Back Malaria Partnership and is on the board of directors of several notable global health organizations. She is an agenda contributor of the World Economic Forum.

<span class="mw-page-title-main">HIV/AIDS in the Democratic Republic of the Congo</span>

The Democratic Republic of the Congo was one of the first African countries to recognize HIV, registering cases of HIV among hospital patients as early as 1983.

HIV/AIDS in Eswatini was first reported in 1986 but has since reached epidemic proportions. As of 2016, Eswatini had the highest prevalence of HIV among adults aged 15 to 49 in the world (27.2%).

HIV/AIDS is considered the deadliest epidemic in the 21st century. It is transmitted through sex, intravenous drug use and mother-to-child transmission. Zambia is experiencing a generalized HIV/AIDS epidemic, with a national HIV prevalence rate of 11.3% among adults ages 15 to 49 as of 2018. Per the 2000 Zambian census, the people affected by HIV/AIDS constituted 15% of the total population, amounting to one million, of which 60% were women. The pandemic results in increased number of orphans, with an estimated 600,000 orphans in the country. It was prevalent more in urban areas compared to rural and among all provinces, Copperbelt Province and Lusaka Province had higher occurrence.

<span class="mw-page-title-main">HIV/AIDS in Zimbabwe</span> Major public health issue

HIV and AIDS is a major public health issue in Zimbabwe. The country is reported to hold one of the largest recorded numbers of cases in Sub-Saharan Africa. According to reports, the virus has been present in the country since roughly 40 years ago. However, evidence suggests that the spread of the virus may have occurred earlier. In recent years, the government has agreed to take action and implement treatment target strategies in order to address the prevalence of cases in the epidemic. Notable progress has been made as increasingly more individuals are being made aware of their HIV/AIDS status, receiving treatment, and reporting high rates of viral suppression. As a result of this, country progress reports show that the epidemic is on the decline and is beginning to reach a plateau. International organizations and the national government have connected this impact to the result of increased condom usage in the population, a reduced number of sexual partners, as well as an increased knowledge and support system through successful implementation of treatment strategies by the government. Vulnerable populations disproportionately impacted by HIV/AIDS in Zimbabwe include women and children, sex workers, and the LGBTQ+ population.

UNAIDS has said that HIV/AIDS in Indonesia is one of Asia's fastest growing epidemics. In 2010, it is expected that 5 million Indonesians will have HIV/AIDS. In 2007, Indonesia was ranked 99th in the world by prevalence rate, but because of low understanding of the symptoms of the disease and high social stigma attached to it, only 5-10% of HIV/AIDS sufferers actually get diagnosed and treated. According to the a census conducted in 2019, it is counted that 640,443 people in the country are living with HIV. The adult prevalence for HIV/ AIDS in the country is 0.4%. Indonesia is the country is Southeast Asia to have the most number of recorded people living with HIV while Thailand has the highest adult prevalence.

Honduras is the Central American country most adversely affected by the HIV/AIDS epidemic. It is estimated that the prevalence of HIV among Honduran adults is 1.5%.

<span class="mw-page-title-main">HIV/AIDS in Haiti</span>

With an estimated 150,000 people living with HIV/AIDS in 2016, Haiti has the most overall cases of HIV/AIDS in the Caribbean and its HIV prevalence rates among the highest percentage-wise in the region. There are many risk-factor groups for HIV infection in Haiti, with the most common ones including lower socioeconomic status, lower educational levels, risky behavior, and lower levels of awareness regarding HIV and its transmission.

<span class="mw-page-title-main">HIV/AIDS in Canada</span>

HIV/AIDS was first detected in Canada in 1982. In 2018, there were approximately 62,050 people living with HIV/AIDS in Canada. It was estimated that 8,300 people were living with undiagnosed HIV in 2018. Mortality has decreased due to medical advances against HIV/AIDS, especially highly active antiretroviral therapy (HAART).

Discrimination against people with HIV/AIDS or serophobia is the prejudice, fear, rejection, and stigmatization of people with HIV/AIDS. Marginalized, at-risk groups such as members of the LGBTQ+ community, intravenous drug users, and sex workers are most vulnerable to facing HIV/AIDS discrimination. The consequences of societal stigma against PLHIV are quite severe, as HIV/AIDS discrimination actively hinders access to HIV/AIDS screening and care around the world. Moreover, these negative stigmas become used against members of the LGBTQ+ community in the form of stereotypes held by physicians.

Since reports of emergence and spread of the human immunodeficiency virus (HIV) in the United States between the 1970s and 1980s, the HIV/AIDS epidemic has frequently been linked to gay, bisexual, and other men who have sex with men (MSM) by epidemiologists and medical professionals. It was first noticed after doctors discovered clusters of Kaposi's sarcoma and pneumocystis pneumonia in homosexual men in Los Angeles, New York City, and San Francisco in 1981. The first official report on the virus was published by the Center for Disease Control (CDC) on June 5, 1981 and detailed the cases of five young gay men who were hospitalized with serious infections. A month later, The New York Times reported that 41 homosexuals had been diagnosed with Kaposi's sarcoma, and eight had died less than 24 months after the diagnosis was made.

<span class="mw-page-title-main">Quarraisha Abdool Karim</span>

Quarraisha Abdool Karim is an infectious diseases epidemiologist and co-founder and Associate Scientific Director of CAPRISA. She is a Professor in Clinical Epidemiology, Columbia University, New York and Pro-Vice Chancellor for African Health, University of KwaZulu-Natal, South Africa.

<span class="mw-page-title-main">Salim Abdool Karim</span> South African medical researcher

Salim S. Abdool Karim, MBChB, MMed, MS(Epi), FFPHM, FFPath (Virol), DipData, PhD, DSc(hc) is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives

<span class="mw-page-title-main">John Nkengasong</span> Cameroonian virologist, director of Africa CDC

John N. Nkengasong is a Cameroonian-American virologist serving as the Global AIDS Coordinator in the Biden administration since 2022. He previously worked as the Director of the Africa Centres for Disease Control and Prevention from 2016 to 2022, as well as at the World Health Organization (WHO) and Centers for Disease Control and Prevention. During the COVID-19 pandemic, Nkengasong was appointed the WHO Special Envoy for Africa.

References

  1. "Holistic Treatment in Haiti: Implications from a Groundbreaking Study — AIDS Issues Update — Housing Works". Housingworks.org. 2012-07-26. Retrieved 2016-08-17.
  2. "UNAIDS Science now". Sciencenow.unaids.org. 2006-05-16. Retrieved 2016-08-17.
  3. Marc LG, Henderson WR, Desrosiers A, Testa MA, Jean SE, Akom EE (2014). "Reliability and validity of the Haitian Creole PHQ-9". Journal of General Internal Medicine. 29 (12): 1679–86. doi:10.1007/s11606-014-2951-5. PMC   4242883 . PMID   25092004.
  4. Marc LG, Patel-Larson A, Hall HI, Hughes D, Alegría M, Jeanty G, Eveillard YS, Jean-Louis E (2010). "HIV among Haitian-born persons in the United States, 1985-2007". AIDS. 24 (13): 2089–97. doi:10.1097/QAD.0b013e32833bedff. PMC   2918877 . PMID   20543655.
  5. Linda Marc-Clérismé. "Linda Marc-Clérismé". The Haitian Roundtable. Retrieved 2016-08-17.
  6. "Home". The Haitian Roundtable. 2016-01-28. Retrieved 2016-08-17.
  7. "Caribbean Financial News". Caribbeanfinancials.com. 2010-07-15. Retrieved 2016-08-17.
  8. "Archived copy" (PDF). www.lauvac-architect.com. Archived from the original (PDF) on 13 July 2011. Retrieved 17 January 2022.{{cite web}}: CS1 maint: archived copy as title (link)
  9. "Census Bureau Names Linda Marc to National Advisory Committee on Racial, Ethnic and Other Populations - Miscellaneous - Newsroom - U.S. Census Bureau". Census.gov. Retrieved 2016-08-17.